CYP2C19 genotype-guided antithrombotic treatment versus conventional clopidogrel therapy in peripheral arterial disease: study design of a randomized controlled trial (GENPAD)
J. Kranendonk*, L. H. Willems, RJ van der Vijver-Coppen, M. Coenen, E. Adang, R. Donders, C. J. Zeebregts, V. H.M. Deneer, M. M.P.J. Reijnen, C. Kramers, M. C. Warlé
Dive into the research topics of 'CYP2C19 genotype-guided antithrombotic treatment versus conventional clopidogrel therapy in peripheral arterial disease: study design of a randomized controlled trial (GENPAD)'. Together they form a unique fingerprint.